Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Antonio Brugarolas"'
Autor:
Juan J. Mata-Molanes, Joseba Rebollo-Liceaga, Elena Mª Martínez-Navarro, Ramón González Manzano, Antonio Brugarolas, Manel Juan, Manuel Sureda
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Therapeutic monoclonal antibodies (mAbs), including immune checkpoint inhibitors (ICIs), are an important breakthrough for the treatment of cancer and have dramatically changed clinical outcomes in a wide variety of tumours. However, clinical respons
Externí odkaz:
https://doaj.org/article/c4184db2acb74038845fae3fb3915c94
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-23 (2021)
Abstract Background Muscle invasive urothelial bladder carcinoma (MIBC) present RB1 and TP53 somatic alterations in a variable percentage of tumors throughout all molecular subtypes. MIBCs with neuroendocrine features have a high response rate to imm
Externí odkaz:
https://doaj.org/article/2a5b8373170341f6939d5ea8337b9dd6
Autor:
Nuria Javaloyes, Aurora Crespo, M. Carmen Redal, Antonio Brugarolas, Lara Botella, Vanesa Escudero-Ortiz, Manuel Sureda
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
BackgroundDiagnosis and treatment of differentiated thyroid carcinomas (DTC) cause anxiety and depression. Additionally, these patients suffer hormonal alterations that are associated with psychological symptoms (e.g., changes in mood, emotional inst
Externí odkaz:
https://doaj.org/article/0a3c0b3c69e0401f98349b664c08c2ed
Autor:
Aurora Crespo-Jara, Maria Carmen Redal-Peña, Elena Maria Martinez-Navarro, Manuel Sureda, Francisco Jose Fernandez-Morejon, Francisco J. Garcia-Cases, Ramon Gonzalez Manzano, Antonio Brugarolas
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-15 (2018)
Abstract Background Building a universal genomic signature predicting the intensity of FDG uptake in diverse metastatic tumors may allow us to understand better the biological processes underlying this phenomenon and their requirements of glucose upt
Externí odkaz:
https://doaj.org/article/45ba77917604499e97bc4ce9029022ed
Publikováno v:
Therapeutic Drug Monitoring. 43:447-450
We describe a clinical case of an 84-year-old man diagnosed with non-small cell lung carcinoma and epidermal growth factor receptor mutation, who was treated with erlotinib, with doses adjusted by therapeutic drug monitoring. This case involved a cle
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-23 (2021)
BMC Cancer
BMC Cancer
Background Muscle invasive urothelial bladder carcinoma (MIBC) present RB1 and TP53 somatic alterations in a variable percentage of tumors throughout all molecular subtypes. MIBCs with neuroendocrine features have a high response rate to immunity che
Autor:
Alejandro Paz Yáñez, Rodolfo Martín Diaz, Paula Muñoz Muñoz, Jose Rolando Ortega Ramírez, Pedro Bretcha Boix, Antonio Brugarolas Masllorens
Publikováno v:
European Journal of Surgical Oncology. 49:e94
Autor:
Joseba Rebollo, Ramón González-Manzano, Manuel Sureda, Elena Ma Martínez, Elena Monedero, Pedro Bretcha, Antonio Brugarolas
Publikováno v:
Journal of Clinical Oncology. 40:e13000-e13000
e13000 Background: A small number of breast cancer patients develops long-lasting loco-regional cutaneous recurrent disease with a delayed appearance of systemic disease. We recently have observed a favourable immunological signature in one patient a
Autor:
Yáñez, Alejandro Paz, Diaz, Rodolfo Martín, Muñoz, Paula Muñoz, Ortega Ramírez, Jose Rolando, Boix, Pedro Bretcha, Masllorens, Antonio Brugarolas
Publikováno v:
In European Journal of Surgical Oncology February 2023 49(2):e94-e94
Autor:
Antonio Brugarolas Masllorens, Juan J. Mata-Molanes, Elena Mª Martínez Navarro, Manuel Sureda González, Belén Valenzuela Jiménez
Publikováno v:
Targeted Oncology. 12:289-299
Cytokine-induced killer (CIK) cells form under certain stimulation conditions in cultures of peripheral blood mononuclear cells (PBMCs). They are a heterogeneous immune cell population and contain a high percentage of cells with a mixed T-NK phenotyp